“In the context of the dual impact of African swine fever and new coronavirus pneumonia, and the Ministry of Agriculture and Rural Affairs’ introduction of the requirement of ‘forbidding antibiotics in feed and reducing antibiotics in breeding’, traditional Chinese veterinary medicine has ushered in unprecedented development opportunities.” Recently Mr. Miao Xuerong (hereinafter referred to as "Mr. Miao"), chairman of Zhejiang Jindakang Animal Health Products Co., Ltd. (hereinafter referred to as "Jindakang"), said in an exclusive interview with a reporter from Zhudou Rong Media that the traditional Chinese medicine industry has received unprecedented attention, which has undoubtedly promoted traditional Chinese veterinary medicine. industrial development. African swine fever is the number one problem in the pig industry, and there are currently no effective vaccines and treatments. Practice has proven that traditional Chinese veterinary medicine plays a major role in protecting susceptible animals by improving the non-specific immunity of pigs.

“Developing Chinese veterinary drugs, focusing on Chinese veterinary drugs, and deeply cultivating Chinese veterinary drugs.” With this original intention, Mr. Miao hopes that Jin Dakang can ride on the wind, soar upward, stand at the top of the industry, and become even more The most important thing is to realize the vision of "let animals grow healthier and hope that human life will be better".

Chairman Miao Xuerong of Zhejiang Jindakang Animal Health Products Co., Ltd.

Gathering momentum to “develop Chinese veterinary drugs, focus on Chinese veterinary drugs, and deepen the cultivation of Chinese veterinary drugs”

《Pig "Double": Jin Dakang was established in 1995. Mr. Miao, why did you choose to enter the Chinese veterinary drug industry? Please introduce your original intention of founding Jindakang and its development in recent years.

Mr. Miao: I used to work at an animal husbandry and veterinary station. In the 1980s, there was still a shortage of animal medicines. When I went to the countryside to treat animals, I would use some Chinese herbal medicines, and I would often receive unexpected advice. Efficacy. Moreover, I have personal experience with the miraculous therapeutic effects of Chinese herbal medicine. In my early years, I suffered from drug-induced hepatitis and developed systemic jaundice. Treatment for many days was ineffective. I then used folk remedies, crushing fresh herbs and applying them on the inner side of my upper arm. The jaundice began to subside the next day, and I recovered after 3 days.

In the 1990s, with the surging tide of reform and opening up, I resigned and founded Zhejiang Jindakang Animal Health Products Co., Ltd. At the beginning, I was not very clear about the development direction of the company until 2000. When I went to Europe to inspect the local breeding industry in 2016, I found that Europe has extremely strict regulations and restrictions on the use of antibiotics. I believe that with the development of the domestic economy, China will definitely enter the era of "reducing, limiting, and banning antibiotics." At that time, I was thinking about using traditional Chinese medicine to replace antibiotics in treating diseases. It was from then on that I became determined Developing beliefs in veterinary medicine.

Looking back from the early days of entrepreneurship to the present, I always feel that "developing Chinese veterinary medicine, focusing on Chinese veterinary medicine, and deeply cultivating Chinese veterinary medicine" is a very meaningful thing and a career worth persisting for a lifetime. This is my original intention.

In recent years, due to the abuse of antibiotics, a series of problems such as the safety of livestock products and the residue of harmful substances have become prominent. In 2018, the "Notice of the General Office of the Ministry of Agriculture and Rural Affairs on Carrying out Pilot Work on the Action to Reduce the Use of Veterinary Antimicrobials" clarified the timetable for reducing and limiting antibiotics on the breeding side. The general trend of "limiting resistance" has been set. The introduction of these industrial policies has provided unlimited business opportunities and development space for the research and development, production and operation of Chinese veterinary drugs.

In order to improve the company's corporate management level and development potential and keep up with the rapid development of the veterinary drug industry, the company invested 150 million yuan in 2014 to carry out secondary upgrades at the original site. If an enterprise wants to develop, product quality is the key and scientific management is fundamental. Management and technology are the two wheels that ensure the healthy and rapid development of an enterprise, and neither is indispensable. We use the perspective of market and technology to create a green high-end brand of Chinese veterinary drugs, and our products are highly recognized and trusted by the majority of breeding companies.

A corner of Jin Dakang

"Pig Pocket": What was the biggest problem Jin Dakang encountered along the way? How was it resolved?

Mr. Miao: As a Chinese veterinary drug company, it needs inheritance and accumulation. In the 25 years since its establishment, talent issues have been the biggest bottleneck and problem in the company's development. The competition among enterprises, on the surface, is a competition of products, but in fact it is a competition of technical level, financial strength and human resources. Whoever occupies the commanding heights of talents will take the initiative.

The shortage of Chinese veterinary medicine professionals and innovative talents has greatly restricted the innovation and R&D capabilities of enterprises. The research and development of traditional Chinese veterinary medicine requires an all-round, multi-field professional team, involving knowledge of traditional Chinese veterinary medicine, animal husbandry veterinary medicine/veterinary clinical, pharmacy, pharmacy, traditional Chinese medicine and other knowledge. In addition to establishing its own R&D team, Jindakang has also vigorously implemented the "brain borrowing project" and established a close industry-university-research cooperation mechanism with scientific research institutes such as Jilin University, Zhejiang University, Nanjing Agricultural University, and Zhejiang Academy of Agricultural Sciences. The advancement of science and technology promotes the improvement of product technical content, which in turn promotes the growth of corporate efficiency, putting the company on a virtuous cycle of development.

"Pig Pocket": Over the years, Jin Dakang has received many honors. At the beginning of 2020, Jindakang successively won the honorary titles of "Jinhua Patent Demonstration Enterprise", "Jinhua Trademark Brand Demonstration Enterprise", and "2019 Safe Consumption Unit". In your opinion, what are the core advantages of Jindakang’s steady development?

Mr. Miao: After more than 20 years of continuous progress, Jin Dakang has achieved certain results in the field of traditional Chinese veterinary medicine. I think the core advantages mainly include two aspects.

First, the biggest feature of traditional Chinese veterinary medicine is the holistic concept and syndrome differentiation and treatment, which is also the essence of traditional Chinese veterinary medicine. From the four diagnosis, eight cardinal principles, syndrome differentiation to treatment, treatment principles, prescriptions, and then to the high degree of unity of the entire system such as the principles, methods, prescriptions, and medicines of medication, this has put forward very high requirements for the research and development of traditional Chinese and veterinary medicine. Jindakang's R&D team integrates clinical experts in animal husbandry and veterinary medicine, traditional Chinese veterinary medicine, traditional Chinese medicine, pharmaceutics, pharmacology, pathology, molecular biology and other disciplines to achieve the integration of disease and medicine. This is the core of Jindakang's product research and development. location. Jindakang not only attaches great importance to the construction of its internal core team, but also hires a number of well-known experts in various fields of the industry to form a strong expert think tank, which provides strong backing for Jindakang's product research and development. This is also the unique way that Jin Dakang’s traditional Chinese and veterinary medicine products have been in an invincible position in the market for more than 20 years, and it is also one of the reasons why Jin Dakang’s products have endured for many years.

Second, Jin Dakang's R&D team always follows the essence of traditional Chinese veterinary medicine, studies the occurrence and development of diseases from the frontline of clinical practice, and combines the epidemic characteristics, clinical symptoms, and autopsy characteristics to form a "one The characteristics of "one medicine for each disease, one product for each syndrome". At the same time, modern traditional Chinese medicine pharmaceutical technology is used to strictly follow the principle of quality first from medicinal material procurement, processing to preparation process. After more than 20 years of exploration, hard work and market testing, Jin Dakang has formed the unique and distinctive characteristics of traditional Chinese veterinary medicine. There are quick treatment drugs: P-Te, Supai, Qiqiqi, etc.; preventive health drugs: Qizhen Zengwu, Yinzhi Jiedu, Shenqi, etc.; drugs to improve production performance: Zengjingbao, Yunbao, Muzijian, Jianzhi A series of products represented by Bao etc. Starting from three different levels: responding to acute animal diseases, alleviating sub-health and improving production performance, it covers the common problems existing in current livestock and poultry breeding, effectively prevents and controls related diseases caused by blue ears, rings, etc., and improves the economic benefits of breeding. .

Take advantage of the situation to move towards "specialization, precision, breadth and depth"

"Pig Pocket": What impact will African swine fever and new coronavirus pneumonia epidemics have on the development of the Chinese veterinary drug industry? ?

Mr. Miao: As COVID-19 is raging around the world, traditional Chinese veterinary medicine has played an important role in epidemic prevention and control, and the results achieved are obvious to all. According to reports, clinical efficacy observations show that the total effective rate of traditional Chinese medicine reaches more than 90%.

African swine fever has been prevalent for nearly 100 years, and there has been no effective vaccine or treatment. Since the outbreak occurred in China in 2018, traditional Chinese veterinary medicine has played a major role in protecting susceptible animals by improving the non-specific immunity of pigs.

In the face of two major epidemics, the development of traditional Chinese veterinary medicine has encountered major opportunities, but at the same time it also faces some helplessness.

Pros: Accelerate the rapid development of the entire traditional Chinese medicine industry. From the central to local governments, many provinces have developed the traditional Chinese medicine industry as a key industry and introduced a series of policies. The traditional Chinese medicine industry has received unprecedented attention, and it has also promoted the development of the traditional Chinese veterinary medicine industry.

Disadvantages: In view of the significant curative effect of traditional Chinese medicine on COVID-19, people's demand for traditional Chinese medicine has increased significantly, resulting in a sharp increase in the price of traditional Chinese medicine, which has had a huge impact on the traditional Chinese veterinary medicine industry. In addition, many companies have invested in the field of Chinese veterinary drugs, causing frequent market chaos and even disorderly competition.

"Zhudou": What factors do you think are restricting the development of the Chinese veterinary drug industry? How should Chinese veterinary drug companies respond?

Mr. Miao: From a macro perspective, vaccines and chemical drugs still dominate. From industrial design, policy promulgation, production enterprises to talent training in universities, research institutions, breeding operations, etc., people generally have certain biases in their understanding of Chinese veterinary drugs. Specific manifestations are in the following aspects:

Specialized - Talents are not professional enough: Traditional Chinese veterinary medicine takes syndrome differentiation and treatment and the unity of nature and man as its core ideas. There are very few talents who can use it skillfully and can observe the disease. There are even fewer talents who can develop and prescribe effective production prescriptions, as well as comprehensively control the quality of Chinese medicinal materials, processing, extraction, and process preparations. This has caused great obstacles to the development of the Chinese veterinary drug industry.

Insufficient selection of medicinal materials: veterinarians and human doctors share medicinal materials and compete with each other for resources. Affected by the COVID-19 epidemic, the prices of many medicinal materials have skyrocketed. For example, Atractylodes macrocephala has skyrocketed from about 30 yuan/kg to more than 150 yuan/kg in a short period of time.

Wide - not widely used: The application of traditional Chinese and veterinary medicine products requires symptomatic medication, and different drug treatment options are required at different stages of disease development. For example: in the treatment of febrile diseases, in the early stage of development, pungent and cool medicines such as Shuanghuanglian and Yinqiao Powder should be used to relieve the symptoms; in the middle stage of development, Qingwen Baidu Powder should be used to clear Qi and blood; in the late stage of development, use Sini Decoction restores Yang and saves Ni.

Deep - Insufficient understanding: Due to the lack of talents, mixed products, substandard quality and other problems in the traditional Chinese veterinary medicine industry, the recognition of traditional Chinese veterinary medicine by the entire industry is too low. People generally believe that Chinese veterinary medicine Veterinary drugs have poor efficacy, long treatment courses and high costs, which have a negative impact on the development of the entire industry.

In view of the above problems, Jindakang has mainly taken the following measures:

First, attach importance to research and development and cultivate talents. Jindakang's independent research and development team is closely integrated with external expert think tanks. Product development originates from the clinical frontline, combined with the laws of disease occurrence and development, using syndrome differentiation and treatment methods, and strictly controlling all aspects of product production. The developed products have the characteristics of "one disease, one drug, one disease, one drug, one drug". The characteristics of "Zhengyipin" solve the problem of syndrome differentiation required for clinical application, greatly facilitate clinical use, and at the same time improve clinical efficacy.

Second, seek innovation and optimize resources. In terms of product design and research and development, we broaden our research and development ideas and strive to seek new medicinal resources. For example, we obtained three new types of veterinary drugs - ginseng stem and leaf total saponin granules, which use ginseng by-products and use ginseng stems and leaves to replace expensive Ginseng can effectively utilize resources, avoid competition with human medicine for resources, and effectively protect the environment.

Third, strengthen promotion and establish the brand. On the basis of making our products refined, specialized and strong, in order to better guide clinical applications, we organize a team of technical experts to provide one-on-one services. Through a series of activities such as "Spring Breeze Action" and "President's Quality Journey", we And continue to promote Jin Dakang's traditional Chinese and veterinary medicine concepts in professional industry media such as "Zhudou Forum".

Fourth, focus on products and precise positioning. For the first time in the industry, Jin Dakang proposed the concept of "increasing immunity and detoxification". Under the current complicated situation of pig diseases, it launched the "Three Treasures of Pig Farms" program of increasing immunity of Qizhen, detoxifying Yinzhi and Supai, and its application in pig farms has achieved remarkable results. effectiveness.

Modern Chinese veterinary drug production workshop

Take advantage of the trend to "let animals grow healthier and hope that human life will be better"

"Pig Pocket": You How do you view the future development trend of the traditional Chinese veterinary medicine industry?

Mr. Miao: Against the backdrop of the dual impact of African swine fever and COVID-19, and the Ministry of Agriculture and Rural Affairs’ introduction of the requirement to “ban antibiotics in feed and reduce antibiotics in breeding”, traditional Chinese veterinary medicine has ushered in an unprecedented development development opportunities.

After experiencing abnormal development stages such as large compound preparations, illegal additions, and abuse of antibiotics, the national level has adopted mandatory requirements (successively issuing multiple notices and announcements), standardizing production (implementing the new version of veterinary drug GMP), and strengthening supervision. (Implementation of QR codes, increased market spot checks) and other measures to regulate the healthy development of the entire industry. As a manufacturer of traditional Chinese and veterinary medicine, ensuring the effectiveness of traditional Chinese and veterinary medicine products is the prerequisite, safety is the guarantee, and stable quality is the foundation. Each enterprise is based on its own characteristics, strives to achieve what others don't have, and what others have, I have the best, and continue to cultivate internal strength. I believe that Chinese veterinary drug enterprises will eventually be able to break out of their cocoons and become butterflies.

"Pig Pocket": As the helmsman and leader, please describe Jin Dakang's future development blueprint.

Mr. Miao: The current global economic recession is obvious, and many industries are on thin ice and are surrounded by crises. However, "opportunities" and "dangers" often coexist, and we must see opportunities from crises. Jin Dakang will not forget his original intention and continue to forge ahead.

To run a business, we must start from the details and work hard on our internal skills. Jindakang will continue to uphold the corporate spirit of "integrity, diligence, pragmatism and innovation", focus on and deepen the field of traditional Chinese veterinary medicine, and focus on the two core goals of improving product quality and service quality to build the first brand of traditional Chinese veterinary medicine.

When making products, we need to be specialized, strong and unique. Give full play to the unique advantages of "one disease, one drug, one certificate, one product", insist on applying the concepts of high efficiency, no resistance, and economy into clinical practice, maximize the economic benefits of breeding enterprises, and contribute due strength to the animal husbandry industry.

In providing services, we require refinement and excellence. With a "one-on-one" service model between technical experts and breeding enterprises, Jin Dakang's three-level thinking of "rapid treatment, efficient health care, and significantly improved production performance" has always been implemented in clinical applications, effectively improving the production performance of breeding enterprises, and ultimately Achieve win-win situation.

Jindakang will adhere to the green path, provide a leading model for reducing, limiting and prohibiting antibiotics, and ultimately realize the beautiful vision of "making animals grow healthier and hoping for a better human life".